NO20030918D0 - Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer - Google Patents

Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer

Info

Publication number
NO20030918D0
NO20030918D0 NO20030918A NO20030918A NO20030918D0 NO 20030918 D0 NO20030918 D0 NO 20030918D0 NO 20030918 A NO20030918 A NO 20030918A NO 20030918 A NO20030918 A NO 20030918A NO 20030918 D0 NO20030918 D0 NO 20030918D0
Authority
NO
Norway
Prior art keywords
protein transferase
transferase inhibitors
farnesyl protein
antitumor compounds
tricyclic
Prior art date
Application number
NO20030918A
Other languages
English (en)
Other versions
NO20030918L (no
Inventor
F George Njoroge
Bancha Vibulbhan
Alan Bruce Cooper
Timothy Guzi
Dinanath F Rane
Keith P Minor
Ronald J Doll
Viyyoor Moopil Girijavallabhan
Bama Santhanam
Patrick A Pinto
Hugh Y Zhu
Kartik M Keertikar
Carmen S Alvarez
Walter Robert Bishop
James J S Wang
Jagdish A Desai
John J Baldwin
Ge Li
Chia-Yu Huang
Ray A James
Original Assignee
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacopeia Inc filed Critical Pharmacopeia Inc
Publication of NO20030918D0 publication Critical patent/NO20030918D0/no
Publication of NO20030918L publication Critical patent/NO20030918L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
NO20030918A 2000-08-30 2003-02-27 Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer NO20030918L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22918300P 2000-08-30 2000-08-30
PCT/US2001/026792 WO2002018368A1 (en) 2000-08-30 2001-08-28 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors

Publications (2)

Publication Number Publication Date
NO20030918D0 true NO20030918D0 (no) 2003-02-27
NO20030918L NO20030918L (no) 2003-04-29

Family

ID=22860141

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030918A NO20030918L (no) 2000-08-30 2003-02-27 Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer

Country Status (27)

Country Link
US (1) US20020198216A1 (no)
EP (1) EP1313725B1 (no)
JP (1) JP2004513885A (no)
KR (1) KR20030034161A (no)
CN (1) CN100384837C (no)
AR (1) AR033680A1 (no)
AT (1) ATE359281T1 (no)
AU (2) AU2001288451C1 (no)
BR (1) BR0113675A (no)
CA (1) CA2420673A1 (no)
CO (1) CO5640109A2 (no)
DE (1) DE60127846T2 (no)
EC (1) ECSP034494A (no)
ES (1) ES2284686T3 (no)
HK (1) HK1054548B (no)
HU (1) HUP0302942A3 (no)
IL (1) IL154528A0 (no)
MX (1) MXPA03001849A (no)
NO (1) NO20030918L (no)
NZ (1) NZ524246A (no)
PE (1) PE20020486A1 (no)
PL (1) PL361103A1 (no)
RU (1) RU2293734C9 (no)
SK (1) SK2292003A3 (no)
TW (1) TWI268280B (no)
WO (1) WO2002018368A1 (no)
ZA (1) ZA200301545B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
JP2004529904A (ja) * 2001-03-14 2004-09-30 ブリストル−マイヤーズ スクイブ カンパニー 増殖性疾患の治療のためのエポシロン類似体および化学療法剤の組み合わせ
JP2005531488A (ja) * 2001-10-09 2005-10-20 ザ・ユニバーシティ・オブ・シンシナティ 甲状腺癌を処置するためのegf受容体阻害剤
JP2005511663A (ja) * 2001-11-30 2005-04-28 シェーリング コーポレイション 癌に対する医薬の製造のための、他の抗腫瘍性剤と組み合わせたファルネシルタンパク質トランスフェラーゼインヒビターの使用
US20040006087A1 (en) * 2001-12-03 2004-01-08 Schering Corporation Method of treating cancer using FPT inhibitors and antineoplastic agents
US20030195192A1 (en) * 2002-04-05 2003-10-16 Fortuna Haviv Nicotinamides having antiangiogenic activity
US20040014744A1 (en) * 2002-04-05 2004-01-22 Fortuna Haviv Substituted pyridines having antiangiogenic activity
JP4921965B2 (ja) 2003-03-27 2012-04-25 ランケナー インスティテュート フォー メディカル リサーチ 癌治療新規方式
CA2525987A1 (en) * 2003-06-05 2005-01-06 Charles Achkar Methods of treating hyperproliferative cell disorders
RU2431500C2 (ru) * 2003-06-09 2011-10-20 Самуэль ВАКСАЛ Способ ингибирования рецепторных тирозинкиназ с помощью внеклеточного антагониста и внутриклеточного антагониста
TW200510384A (en) 2003-08-07 2005-03-16 Schering Corp Novel farnesyl protein transferase inhibitors as antitumor agents
US7592466B2 (en) 2003-10-09 2009-09-22 Abbott Laboratories Ureas having antiangiogenic activity
EP1831200A2 (en) * 2004-12-21 2007-09-12 Schering Corporation Novel farnesyl protein transferase inhibitors as antitumor agents
WO2010006432A1 (en) 2008-07-14 2010-01-21 Queen's University At Kingston Pharmaceutical compositions comprising ret inhibitors and methods for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
PE92098A1 (es) * 1996-07-31 1998-12-31 Schering Corp N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
US6071907A (en) * 1996-09-13 2000-06-06 Schering Corporation Tricyclic compounds useful as FPT inhibitors
US5925648A (en) * 1997-07-29 1999-07-20 Schering Corporation Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase
TR200101754T2 (tr) * 1998-12-18 2002-05-21 Schering Corporation Farnezil protein transferaz inhibitörleri

Also Published As

Publication number Publication date
HK1054548B (zh) 2007-10-18
NZ524246A (en) 2004-11-26
MXPA03001849A (es) 2003-06-04
CO5640109A2 (es) 2006-05-31
IL154528A0 (en) 2003-09-17
CN100384837C (zh) 2008-04-30
RU2293734C9 (ru) 2007-10-10
NO20030918L (no) 2003-04-29
AR033680A1 (es) 2004-01-07
WO2002018368A1 (en) 2002-03-07
ATE359281T1 (de) 2007-05-15
ZA200301545B (en) 2004-06-22
EP1313725B1 (en) 2007-04-11
RU2293734C2 (ru) 2007-02-20
US20020198216A1 (en) 2002-12-26
ES2284686T3 (es) 2007-11-16
SK2292003A3 (en) 2003-08-05
AU2001288451C1 (en) 2008-03-06
ECSP034494A (es) 2003-04-25
CN1471524A (zh) 2004-01-28
KR20030034161A (ko) 2003-05-01
DE60127846D1 (en) 2007-05-24
EP1313725A1 (en) 2003-05-28
AU2001288451B2 (en) 2007-05-24
PL361103A1 (en) 2004-09-20
HK1054548A1 (en) 2003-12-05
CA2420673A1 (en) 2002-03-07
JP2004513885A (ja) 2004-05-13
AU8845101A (en) 2002-03-13
HUP0302942A3 (en) 2007-02-28
BR0113675A (pt) 2003-06-24
TWI268280B (en) 2006-12-11
DE60127846T2 (de) 2008-03-06
HUP0302942A2 (hu) 2003-12-29
PE20020486A1 (es) 2002-06-14

Similar Documents

Publication Publication Date Title
HK1087122A1 (en) Novel farnesyl protein transferase inhibitors as antitumor agents
AU2001246477A1 (en) Farnesyl protein transferase inhibitor combinations with platinum compounds
NO996571D0 (no) Inhibitorer for farnesyl-protein-transferase
NO20030779L (no) Kondenserte pyrazolderivater som er proteinkinase-inhibitorer
NO20024950D0 (no) 4-Merkaptopyrrolidinderivater som farnesyltransferaseinhibitorer
NO20030918L (no) Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer
DE69924876D1 (de) Farnesyl protein transferase inhibitoren
AU2001235496A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents
AU2001239275A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
ATE255114T1 (de) Tricyclische proteinkinasehemmer
NO20044053L (no) Farnesylproteintransferaseinhibitorer som antitumormidler
AU2001246478A1 (en) Farnesyl protein transferase inhibitor combinations with taxane compounds
AU2001252147A1 (en) Farnesyl protein transferase inhibitor combinations
DK1339695T3 (da) Farnesyltransferase-inhibitorer
NO20012961D0 (no) Trisykliske farnesylproteintransferase-inhibitorer
EE200200206A (et) Farnesüüli transferaasiinhibiitorid
ZA200705126B (en) Novel farnesyl protein transferase inhibitors as antitumor agents
AU3514302A (en) 0ovel farnesyl protein transferase inhibitors
NO20022923D0 (no) Inhibitorer av farnesyl-protein-transferase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application